Fig 1.
Enrollment flow chart for analysis.
Apo A1; apolipoprotein A1, Apo B; apolipoprotein B, DCMC; Daegu catholic medical center, eGFR; estimated glomerular filtration rate, HDL-C; high-density lipoprotein cholesterol, LDL-C; low-density lipoprotein cholesterol, Lp (a); lipoprotein (a), MACE; major cardiovascular adverse event, PCI; percutaneous coronary intervention, TC; total cholesterol.
Table 1.
Characteristics of individuals stratified by tertiles of Apo B/A1 ratio decrease.
Fig 2.
Kaplan-Meier curves of MACE survival rate by tertile of TC/HDL-C ratio at follow-up (A). Kaplan-Meier curves of MACE survival rate by tertile of Apo B/A1 ratio at follow-up (B). Kaplan-Meier curves of MACE survival rate by tertile of TC/HDL-C ratio decrease (C). Kaplan-Meier curves of MACE survival rate by tertile of Apo B/A1 ratio decrease (D). Apo A1; apolipoprotein A1, Apo B; apolipoprotein B, HDL-C; high-density lipoprotein cholesterol, MACE; major cardiovascular adverse event, TC; total cholesterol.
Fig 3.
Kaplan-Meier curves of MACE survival rate by tertile of Lp (a) at index PCI (A). Kaplan-Meier curves of MACE survival rate by tertile of Lp (a) at follow-up (B). Kaplan-Meier curves of MACE survival rate by tertile of Lp (a) decrease (C). Lp (a); lipoprotein (a), MACE; major cardiovascular adverse event, PCI; percutaneous coronary intervention.
Table 2.
Clinical adverse events stratified by tertiles of Apo B/A1 ratio decrease.
Table 3.
Independent predictors for MACEs.
Table 4.
Independent predictors for lowest tertile of Apo B/A1 ratio decrease.